1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Weight Loss Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Appetite Suppression
1.2.3 Increasing Body Metabolism
1.2.4 Interfering with the Digestion Absorption Patterns
1.3 Market by Application
1.3.1 Global Weight Loss Therapeutics Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Retail Pharmacies
1.3.5 Mail Order Pharmacies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Weight Loss Therapeutics Market Perspective (2018-2029)
2.2 Weight Loss Therapeutics Growth Trends by Region
2.2.1 Weight Loss Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Weight Loss Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Weight Loss Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Weight Loss Therapeutics Market Dynamics
2.3.1 Weight Loss Therapeutics Industry Trends
2.3.2 Weight Loss Therapeutics Market Drivers
2.3.3 Weight Loss Therapeutics Market Challenges
2.3.4 Weight Loss Therapeutics Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Weight Loss Therapeutics Players by Revenue
3.1.1 Global Top Weight Loss Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Weight Loss Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Weight Loss Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Weight Loss Therapeutics Revenue
3.4 Global Weight Loss Therapeutics Market Concentration Ratio
3.4.1 Global Weight Loss Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Weight Loss Therapeutics Revenue in 2022
3.5 Weight Loss Therapeutics Key Players Head office and Area Served
3.6 Key Players Weight Loss Therapeutics Product Solution and Service
3.7 Date of Enter into Weight Loss Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Weight Loss Therapeutics Breakdown Data by Type
4.1 Global Weight Loss Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Weight Loss Therapeutics Forecasted Market Size by Type (2024-2029) 5 Weight Loss Therapeutics Breakdown Data by Application
5.1 Global Weight Loss Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Weight Loss Therapeutics Forecasted Market Size by Application (2024-2029) 6 North America
6.1 North America Weight Loss Therapeutics Market Size (2018-2029)
6.2 North America Weight Loss Therapeutics Market Size by Country (2018-2023)
6.3 North America Weight Loss Therapeutics Market Size by Country (2024-2029)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Weight Loss Therapeutics Market Size (2018-2029)
7.2 Europe Weight Loss Therapeutics Market Size by Country (2018-2023)
7.3 Europe Weight Loss Therapeutics Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Weight Loss Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Weight Loss Therapeutics Market Size by Country (2018-2023)
8.3 Asia-Pacific Weight Loss Therapeutics Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Weight Loss Therapeutics Market Size (2018-2029)
9.2 Latin America Weight Loss Therapeutics Market Size by Country (2018-2023)
9.3 Latin America Weight Loss Therapeutics Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Weight Loss Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2018-2023)
10.3 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Weight Loss Therapeutics Introduction
11.1.4 Abbott Revenue in Weight Loss Therapeutics Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Weight Loss Therapeutics Introduction
11.2.4 Sanofi Revenue in Weight Loss Therapeutics Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Weight Loss Therapeutics Introduction
11.3.4 Novo Nordisk Revenue in Weight Loss Therapeutics Business (2018-2023)
11.3.5 Novo Nordisk Recent Development
11.4 Arena Pharmaceuticals
11.4.1 Arena Pharmaceuticals Company Detail
11.4.2 Arena Pharmaceuticals Business Overview
11.4.3 Arena Pharmaceuticals Weight Loss Therapeutics Introduction
11.4.4 Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2018-2023)
11.4.5 Arena Pharmaceuticals Recent Development
11.5 Orexigen Therapeutics
11.5.1 Orexigen Therapeutics Company Detail
11.5.2 Orexigen Therapeutics Business Overview
11.5.3 Orexigen Therapeutics Weight Loss Therapeutics Introduction
11.5.4 Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2018-2023)
11.5.5 Orexigen Therapeutics Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Weight Loss Therapeutics Introduction
11.6.4 Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Weight Loss Therapeutics Introduction
11.7.4 Pfizer Revenue in Weight Loss Therapeutics Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Detail
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Weight Loss Therapeutics Introduction
11.8.4 Novartis AG Revenue in Weight Loss Therapeutics Business (2018-2023)
11.8.5 Novartis AG Recent Development
11.9 Biocon
11.9.1 Biocon Company Detail
11.9.2 Biocon Business Overview
11.9.3 Biocon Weight Loss Therapeutics Introduction
11.9.4 Biocon Revenue in Weight Loss Therapeutics Business (2018-2023)
11.9.5 Biocon Recent Development
11.10 VIVUS
11.10.1 VIVUS Company Detail
11.10.2 VIVUS Business Overview
11.10.3 VIVUS Weight Loss Therapeutics Introduction
11.10.4 VIVUS Revenue in Weight Loss Therapeutics Business (2018-2023)
11.10.5 VIVUS Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Detail
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Weight Loss Therapeutics Introduction
11.11.4 Eli Lilly Revenue in Weight Loss Therapeutics Business (2018-2023)
11.11.5 Eli Lilly Recent Development
11.12 Amgen
11.12.1 Amgen Company Detail
11.12.2 Amgen Business Overview
11.12.3 Amgen Weight Loss Therapeutics Introduction
11.12.4 Amgen Revenue in Weight Loss Therapeutics Business (2018-2023)
11.12.5 Amgen Recent Development
11.13 Zafgen
11.13.1 Zafgen Company Detail
11.13.2 Zafgen Business Overview
11.13.3 Zafgen Weight Loss Therapeutics Introduction
11.13.4 Zafgen Revenue in Weight Loss Therapeutics Business (2018-2023)
11.13.5 Zafgen Recent Development
11.14 Roche
11.14.1 Roche Company Detail
11.14.2 Roche Business Overview
11.14.3 Roche Weight Loss Therapeutics Introduction
11.14.4 Roche Revenue in Weight Loss Therapeutics Business (2018-2023)
11.14.5 Roche Recent Development
11.15 Eisai
11.15.1 Eisai Company Detail
11.15.2 Eisai Business Overview
11.15.3 Eisai Weight Loss Therapeutics Introduction
11.15.4 Eisai Revenue in Weight Loss Therapeutics Business (2018-2023)
11.15.5 Eisai Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
